Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection.
E Mannaert, J Tytgat, P Daenens
Index: J. Anal. Toxicol. 21(3) , 208-12, (1997)
Full Text: HTML
Abstract
A qualitative screening technique was developed for the detection of 2-amino-5-chloropyridine, a newly identified decomposition product of zopiclone and metabolites after alkaline hydrolysis of urine samples. The method was elaborated using a standard operation procedure (Merck Tox Screening System), combining a solid-phase extraction with reversed-phase high-performance liquid chromatography and diode array detection. The limit of detection, expressed as zopiclone concentrations in spiked urine, was found to be 0.5 microg/mL. Field urine samples from a volunteer were positive for 2-amino-5-chloropyridine until 16 h after ingestion of one therapeutic dose of Imovane (7.5 mg zopiclone).
Related Compounds
Related Articles:
2012-10-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 907 , 49-55, (2012)]
Capillary electrophoretic enantioselective determination of zopiclone and its impurities.
2012-06-01
[Electrophoresis 33(11) , 1606-12, (2012)]
2013-01-01
[Int. J. Legal Med. 127(1) , 69-76, (2013)]
Stability tests of zopiclone in whole blood.
2010-07-15
[Forensic Sci. Int. 200(1-3) , 130-5, (2010)]
Zopiclone misuse: an update from Dublin.
2007-01-01
[Drug Alcohol Rev. 26(1) , 83-5, (2007)]